DK

Donald S. Karanewsky

ES E.R. Squibb & Sons.: 50 patents #3 of 513Top 1%
SE Senomyx: 30 patents #10 of 103Top 10%
IP Idun Pharmaceuticals: 17 patents #2 of 26Top 8%
IR Irm: 11 patents #18 of 277Top 7%
LI Ligand Pharmaceuticals Incorporated: 5 patents #36 of 191Top 20%
NA Novartis Ag: 5 patents #875 of 5,128Top 20%
FI Firmenich Incorporated: 4 patents #10 of 66Top 20%
OP Ortho Pharmaceutical: 3 patents #47 of 234Top 25%
BS Bristol-Myers Squibb: 1 patents #2,477 of 3,969Top 65%
📍 Escondido, CA: #5 of 1,330 inventorsTop 1%
🗺 California: #1,449 of 386,348 inventorsTop 1%
Overall (All Time): #9,146 of 4,157,543Top 1%
125
Patents All Time

Issued Patents All Time

Showing 76–100 of 125 patents

Patent #TitleCo-InventorsDate
5504080 Benzo-fused lactams 1996-04-02
5436245 Phosphate substituted amino or imino acids useful as antihypertensives 1995-07-25
5276021 Phosphorus-containing HMG-COA reductase inhibitors, new intermediates and method Michael Badia, Scott A. Biller, Eric M. Gordon, Michael Joseph Sofia 1994-01-04
5194634 Dihydroxyheptanoic acids containing an oxabicycloheptane nucleus useful as antihypercholesterolemic agents 1993-03-16
5189180 Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates 1993-02-23
5157134 Dihydroxyheptanoic acids containing an oxabicycloheptane nucleus useful as antihypercholesterolemic agents 1992-10-20
5124453 Process for preparing certain 5,6,7,8-tetrahydroindolizinyl (ethyl or ethynyl)-hydroxy or methoxy-phosphinyl-3-hydroxy-butanoates and derivatives thereof 1992-06-23
5102875 Phosphonate substituted amino acids useful as antihypertensives 1992-04-07
5091378 Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method Michael Badia, Scott A. Biller, Eric M. Gordon, Michael Joseph Sofia 1992-02-25
5025000 Phosphorus-containing HMG-CoA reductase inhibitor compounds 1991-06-18
5025017 Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates 1991-06-18
5017716 Phosphorous-containing HMG-CoA reductase inhibitors, new intermediates and method Scott A. Biller, Eric M. Gordon 1991-05-21
4910198 1,5-epoxy-2,3,4,5-tetrahydro-1H-3-benzazepins Michael P. Wachter 1990-03-20
4904646 Phosphorus-containing HMG-COA reductase inhibitors Scott A. Biller, Eric M. Gordon 1990-02-27
4873356 Method for preparing phosphinic acids used in preparing ace inhibitors and intermediates produced thereby Edward W. Petrillo, Jr., John K. Thottathil, James E. Heikes, John A. Grosso 1989-10-10
4855426 Process of preparing 1,5-epoxy-2,3,4,5-tetrahydro-1H-3-benzazepins Michael P. Wachter 1989-08-08
4849414 Substituted aminoalkanoylaminoalkyl phosphonate angiotensin converting enzyme inhibitors Melanie J. Loots 1989-07-18
4804770 Process for preparing a keto-phosphonate intermediate useful in preparing HMG-CoA reductase inhibitors 1989-02-14
4761413 1,5-epoxy-2,3,4,5-tetrahydro-1H-3-benzazepins and use in treatment of ulcers Michael P. Wachter 1988-08-02
4745196 Orally active phosphonyl hydroxyacyl prolines Edward W. Petrillo, Jr. 1988-05-17
4721725 Aryl-cycloalkyl[b]pyrrole derivatives Scott A. Biller 1988-01-26
4716155 Phosphorus containing compounds and hypotensive use thereof Edward W. Petrillo, Jr. 1987-12-29
4711884 Thiazine and thiazepine containing compounds 1987-12-08
4703043 Phosphonyl hydroxyacyl amino acid derivatives as antihypertensive Edward W. Petrillo, Jr. 1987-10-27
4686298 Intermediates for alpha-acyloxy phosphonate angiotensin converting enzyme inhibitors Tamara Dejneka 1987-08-11